시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 수혈 진단 시장 보고서(2024년)
Blood Transfusion Diagnostics Global Market Report 2024
상품코드 : 1426177
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,000 ￦ 6,977,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,500 ￦ 10,465,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 10,000 ￦ 13,954,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

수혈 진단 시장 규모는 향후 수년간 급속히 성장할 것으로 예상됩니다. 2028년에는 8.1%의 연간 복합 성장률(CAGR)로 60억 4,000만 달러로 성장할 것으로 예상됩니다. 향후 예상되는 성장은 몇 가지 중요한 요인에 의해 주도될 것으로 예상됩니다. 여기에는 정밀의료에 대한 수요 증가, 수혈 인프라 강화에 대한 투자 증가, 분자 수혈 진단에 대한 수요 증가, 신흥 감염성 질환에 대한 우려, 혈액 안전에 대한 관심 증가 등이 포함됩니다.

매년 수술 건수가 증가함에 따라 수혈 진단에 대한 수요가 증가하고 있습니다. 이러한 진단은 환자에게 수혈하기 전에 헌혈된 혈액을 선별하고 잠재적인 감염을 예방하는 데 매우 중요합니다. 매년 약 3억 1,000만 건의 수술이 이루어지고 있으며, 이러한 수술과 함께 수혈 진단의 필요성도 증가하고 있습니다.

혈액 관련 질환은 수혈 진단 시장 확대에 크게 기여하고 있습니다. 빈혈, 백혈병, 응고 장애와 같은 증상은 조기 발견과 안전한 관리를 위해 정확한 진단이 필요합니다. 2023년 1월 통계에 따르면 백혈병으로 인한 신규 감염자 수는 약 5만 9,610명, 사망자 수는 2만 3,710명, 급성 골수성 백혈병(AML)이 신규 감염자 수 약 2만 380명을 차지할 정도로 이 질환의 유병률은 분명합니다. 이러한 확산으로 인해 최적의 환자 치료를 보장하기 위해 진단을 개선해야 할 필요성이 대두되고 있습니다.

목차

제1장 주요 요약

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 거시경제 시나리오

제5장 세계 시장 규모와 성장

제6장 시장 세분화

제7장 지역과 국가 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 경쟁 벤치마킹

제32장 경쟁 대시보드

제33장 주요 합병과 인수

제34장 향후 전망과 잠재성 분석

제35장 부록

KSA
영문 목차

영문목차

Blood transfusion diagnostics play a crucial role in conducting tests before the transfer of blood between donors and recipients, encompassing assessments like blood grouping and disease screening.

These diagnostics are primarily categorized into instruments and kits, along with reagents and other ancillary tools. Blood transfusion diagnostic kits are instrumental in collecting and safely transfusing blood, utilizing technologies like western blot, ELISA, nucleic acid amplification, fluorescence assays, and rapid testing. These technologies are employed across diverse applications, specifically in blood grouping and disease screening procedures. End-users of blood transfusion diagnostics span various sectors, including hospitals, diagnostic laboratories, blood banks, and companies engaged in plasma fractionation. These entities rely on these diagnostic tools to ensure the safe and accurate transfer of blood components between donors and recipients.

The blood transfusion diagnostics market research report is one of a series of new reports from The Business Research Company that provides blood transfusion diagnostics market statistics, including blood transfusion diagnostics industry global market size, regional shares, competitors with a blood transfusion diagnostics market share, detailed blood transfusion diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the blood transfusion diagnostics industry. This blood transfusion diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The blood transfusion diagnostics market size has grown rapidly in recent years. It will grow from $3.98 billion in 2023 to $4.42 billion in 2024 at a compound annual growth rate (CAGR) of 11.1%. The growth observed in the historical period can be attributed to several key factors. These include the rising frequency of blood transfusions, the emergence of new pathogens necessitating stringent diagnostics, an aging population requiring more transfusions, a growing demand for swift and efficient blood transfusion diagnostics, the increasing prevalence of chronic diseases requiring transfusion support, and an overall rise in the demand for blood products. These elements collectively contributed to the growth and advancements in blood transfusion diagnostics during this period.

The blood transfusion diagnostics market size is expected to see rapidly grown in the next few years. It will grow to $6.04 billion in 2028 at a compound annual growth rate (CAGR) of 8.1%. Anticipated growth in the upcoming period is expected to stem from several key factors. These include the increasing demand for precision medicine, heightened investments in enhancing blood transfusion infrastructure, a growing need for molecular blood transfusion diagnostics, concerns arising from emerging infectious diseases, and an amplified focus on ensuring blood safety.

The demand for blood transfusion diagnostics is on the rise, fueled by the increasing number of surgeries performed annually. These diagnostics are crucial in screening donated blood before transfusion to patients, preventing potential infectious diseases. With an estimated 310 million surgeries conducted each year, the necessity for blood transfusion diagnostics is growing in tandem with these procedures.

Blood-related diseases are contributing significantly to the expansion of the blood transfusion diagnostics market. Conditions like anemias, leukemia, and clotting disorders necessitate precise diagnostics for early detection and safe management. The prevalence of these diseases is evident, with statistics from January 2023 showing approximately 59,610 new cases and 23,710 deaths from leukemia, while acute myeloid leukemia (AML) accounted for around 20,380 new cases. This prevalence drives the need for improved diagnostics to ensure optimal patient care.

The inclination toward nucleic acid amplification testing (NAT) for blood safety and efficiency is growing due to its accuracy in detecting pathogens like bacteria and viruses. This testing method, detecting specific nucleic acids of pathogens in blood, tissue, or urine, offers high sensitivity and early identification of infectious diseases. XCRP Diagnostic Inc. and Luminex Corporations' agreement for the Xtreme Chain Reaction Nucleic Acid Amplification Technology exemplifies the industry's focus on advancing diagnostic capabilities through strategic partnerships.

Innovations in serological testing, such as the Immediate Spin Crossmatch (ISXM) test, are enhancing blood transfusion diagnostics. This test aids in identifying ABO blood type incompatibility between donor red blood cells and recipient serum/plasma. Ortho Clinical Diagnostics' launch of immediate spin crossmatch capabilities on the ORTHO VISION and ORTHO VISION MAX Analyzers in September 2021 underlines the industry's commitment to evolving diagnostic solutions for better donor-recipient matching in transfusions.

Major companies operating in the blood transfusion diagnostics market include BAG Health Care GmbH, Grifols S.A., Bio-Rad LaboratoriesInc., Abbott Laboratories, Immucor Inc., Ortho Clinical Diagnostics, DiaSorin S.p.A, Siemens Healthineers, Thermo Fisher Scientific Inc., Beckman Coulter Inc., Novartis AG, F. Hoffmann-La Roche Ltd., Quotient Limited, HologicInc., Roche Diagnostics, bioMerieux, Diagast SAS, Fujirebio, Biokit S.A., QuidelOrtho Corporation, Gen-Probe, Proteomes Sciences PLC, Danaher Corporation, Immucor Inc., Becton Dickinson and Company, Quotient Biodiagnostics, Thermo Fisher Scientific, Sekisui Diagnostics, Sysmex Corporation, Werfen S.A.

North America was the largest region in the blood transfusion diagnostics market in 2023. Western Europe was the second-largest region in the blood transfusion diagnostics industry. The regions covered in the blood transfusion diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the blood transfusion diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The blood transfusion diagnostics market consists of revenues earned by entities by providing installation and maintenance services. The market value includes the value of related goods sold by the service provider or included within the service offering. The blood transfusion diagnostics market also includes sales of blood transfusion diagnostics devices. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Blood Transfusion Diagnostics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on blood transfusion diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for blood transfusion diagnostics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The blood transfusion diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

Scope

Markets Covered:

Table of Contents

1. Executive Summary

2. Blood Transfusion Diagnostics Market Characteristics

3. Blood Transfusion Diagnostics Market Trends And Strategies

4. Blood Transfusion Diagnostics Market - Macro Economic Scenario

5. Global Blood Transfusion Diagnostics Market Size and Growth

6. Blood Transfusion Diagnostics Market Segmentation

7. Blood Transfusion Diagnostics Market Regional And Country Analysis

8. Asia-Pacific Blood Transfusion Diagnostics Market

9. China Blood Transfusion Diagnostics Market

10. India Blood Transfusion Diagnostics Market

11. Japan Blood Transfusion Diagnostics Market

12. Australia Blood Transfusion Diagnostics Market

13. Indonesia Blood Transfusion Diagnostics Market

14. South Korea Blood Transfusion Diagnostics Market

15. Western Europe Blood Transfusion Diagnostics Market

16. UK Blood Transfusion Diagnostics Market

17. Germany Blood Transfusion Diagnostics Market

18. France Blood Transfusion Diagnostics Market

19. Italy Blood Transfusion Diagnostics Market

20. Spain Blood Transfusion Diagnostics Market

21. Eastern Europe Blood Transfusion Diagnostics Market

22. Russia Blood Transfusion Diagnostics Market

23. North America Blood Transfusion Diagnostics Market

24. USA Blood Transfusion Diagnostics Market

25. Canada Blood Transfusion Diagnostics Market

26. South America Blood Transfusion Diagnostics Market

27. Brazil Blood Transfusion Diagnostics Market

28. Middle East Blood Transfusion Diagnostics Market

29. Africa Blood Transfusion Diagnostics Market

30. Blood Transfusion Diagnostics Market Competitive Landscape And Company Profiles

31. Global Blood Transfusion Diagnostics Market Competitive Benchmarking

32. Global Blood Transfusion Diagnostics Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Blood Transfusion Diagnostics Market

34. Blood Transfusion Diagnostics Market Future Outlook and Potential Analysis

35. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기